639 6396462006 00001 and between those with solidand nonsolidmodel in patients with curative resection revealed that agetumor diameter depth of invasion lymphnode metastasisdifferentiate ID: 947766
Download Pdf The PPT/PDF document "Clinicopathological Properties of Poorly..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
639 : 639-646(2006) Clinicopathological Properties of Poorly-differentiated 0.0001), and between those with solid-and non-solid-model in patients with curative resection revealed that age,tumor diameter, depth of invasion, lymphnode metastasisdifferentiated or undifferentiated (solid-and non-solid-those with differentiated or solid-type tumor
s.However,there was no significant difference in the distribution of 641 Table I. The clinicopathological characteristics of all registered patients (n=1,558). VariablesDifferentiated-typeSolid-typeNon-solid-type (n=1118)(n=138)(n=302)70/446/67239/9973/229Male/Female829/28994/44171/131Presence/Absence54/106410/12841/261Presence/Absence45/107
38/1305/297Lower third4703885Middle third40561107Upper third2182864Entire251146Superficial70459106Well-defined1953042Ill-defined219491547266611050, 33152123100612069T16525465T22634280T3,420342157Presence/Absence375/74368/70202/100Presence/Absence546/57280/58232/70 Presence/Absence372/74666/72133/169 expanding-type tumors (10,11). In our pre
vious study (7),we did not detect a prognostic value of histologicaldifference in survival between patients with solid and 643 Figure 1. Disease-specific survival of registered patients (n=1,558). There was a significant difference in survival between patients with differentiated-(n=1,118) and non-solid-type tumors (n=302) (p)()(0001). Figure
2. tween patients withdifferentiated (n=990) and non-solid tumors (n=226) (p)()(001). between the solid-and non-solid-type was mainly due to the 645 patients with Solid-typeNon-solid-type (n)5-year survival rate (%)(n) 5-year survival rate (%) IB1793.82490.80.8407II2280.44279.80.6925III2171.97336.30.0480 IV333.32414.00.5947 Table IV.Prognos
tic factors assessed by multivariate analysis in patients receiving curative resection. VariablesCoefficientSEHazard ratio (95% CI)70/0.45040.15221.5690 (1.1643-2.1143)0.0031Tumor diameter (mm)0.002050 0.14390.17941.1547 (0.8124-1.6413)0.4225100/0.67860.20921.9711 (1.3081-2.9702)0.0012Depth of invasionT2/T11.73830.32465.6876 (3.0104-10.745
7)T3,4/T12.17630.34028.8132 (4.5244-17.1675)Lymph node metastasispN1/pN00.72820.22932.0714 (1.3214-3.2470)0.0015pN2/pN01.56680.23174.7912 (3.0425-7.5450)pN3/pN02.11360.26538.2779 (4.9214-13.9237)Non-solid/solid, differentiated0.22180.11201.3963 (1.1161-1.2483)0.0439 Present/Absent0.58490.17311.7948 (1.2784-2.5196)0.0007 Table V.Causes of deat
h in patients who underwent curative gastrectomy. DifferentiatedSolidNon-solid (n=174)(n=16)(n=75)Gastric cancer1121257Co-morbid disease27310Other cancers1812 Unknown1526 Table VI.Pattern of recurrence in patients who underwent curativegastrectomy. DifferentiatedSolidNon-solid (n=112)(n=12)(n=57)Peritoneal 42337Hematogenous58613 Lymphatic1237